Table 5.
Frequency of Adverse Effects and Painfulness of the Treatment
| Active Group (n = 104) | Sham Group (n = 132) | ||
|---|---|---|---|
| Local signs | |||
| Tingling | 9.6% | 3.8% | |
| Squeezing | 11.5% | 2.3% | P < .01 |
| Pain | 10.6% | 3.8% | P < .05 |
| Regional signs | |||
| Hemi-facial pain and squeezing | 11.5% | 8.3% | |
| Clenched jaw | 28.8% | 1.5% | P < .0001 |
| Blepharospasm | 14.4% | 0.8% | P < .001 |
| General signs | |||
| Headache | 13.5% | 6.8% | |
| Asthenia | 1.0% | 1.5% | |
| Other complaints | |||
| Noise | 6.7% | 12.9% | |
| Uncomfortable body position | 0.0% | 5.3% | P < .05 |
| Motor threshold | 1.9% | 2.3% | |
| Other | 4.8% | 6.8% | |
| No complaints | 32.7% | 56.1% | P < .0001 |
| Treatment painfulness | |||
| VAS (mean of 4 sessions) | 2.8 ± 1.6 (n = 21) | 1.4 ± 1.7 (n = 28) | P < .05 |